BLUEPRINT MEDICINES CORP (BPMC)
US09627Y1091 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -506.98M | -557.50M | -644.10M | 313.90M | -347.70M | |||
| Depreciation Amortization | 11.66M | 11.70M | 6.50M | 6.60M | 5.30M | |||
| Change In Working Capital | -41.13M | -53.80M | -23.70M | -15.60M | 9.70M | |||
| Interest Paid | 38.47M | 9.80M | N/A | 0.00 | 0.00 | |||
| Taxes Paid | -49.00K | 6.50M | 700.00K | 800.00K | 200.00K | |||
| Other non cash items | 99.60M | 97.30M | 362.60M | 82.20M | 54.70M | |||
| OPERATING CASH FLOW | -436.85M | -502.30M | -298.70M | 387.00M | -278.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -16.06M | -8.90M | -3.10M | -3.20M | -14.00M | |||
| Other Investing Activity | 290.10M | -140.60M | -222.80M | -431.10M | -2.50M | |||
| INVESTING CASH FLOW | 274.04M | -149.50M | -225.90M | -434.20M | -16.50M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 97.93M | 137.80M | N/A | 0.00 | 0.00 | |||
| Stock Issued/Repurchased | 21.34M | 8.20M | 50.70M | 617.80M | 341.00M | |||
| Other Financing Activity | -44.00K | 415.80M | 0.00 | 0.00 | -400.00K | |||
| FINANCING CASH FLOW | 119.22M | 561.80M | 50.70M | 617.80M | 340.60M | |||
| Exchange Rate Effect | 202.00K | -200.00K | -900.00K | -300.00K | 0.00 | |||
| CHANGE IN CASH | -43.38M | -90.20M | -474.80M | 570.30M | 46.10M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -436.85M | -502.30M | -298.70M | 387.00M | -278.00M | |||
| Capital Expenditure | -16.06M | -8.90M | -3.10M | -3.20M | -14.00M | |||
| FREE CASH FLOW | -452.91M | -511.20M | -301.80M | 383.80M | -292.00M | |||
All data in USD